Sale of Tobacco Products Drop by 47% in UK

Apr.18.2023
Sale of Tobacco Products Drop by 47% in UK
UK researchers found tobacco sales dropped 47% in 1400 convenience stores over 3 years, while e-cigarette sales increased.

Recently, researchers in the UK analyzed sales data from nearly 1,400 convenience stores in Scotland, England, and Wales. The results showed that over the course of three years, sales of combustible tobacco had decreased by 47%. Sales of pure tobacco products fell from 11% to 6%, while sales of products containing tobacco mixed with other items decreased from 14% to 9%.


During this period, there was a 16% decrease in the average weekly sales. Researchers pointed out that an increase in the sales of e-cigarettes supported this trend.


However, a study in the United States has found that a ban on e-cigarettes led to an increase in traditional cigarette sales. Following the implementation of a comprehensive ban on flavored e-cigarettes in Massachusetts, the per capita sales of traditional cigarettes were 7.5% higher than expected.


The UK and New Zealand have achieved some success in smoking cessation, recommending electronic cigarettes as a tool for quitting smoking. The smoking rates in the UK and New Zealand have decreased by 13.8% and 10.9% respectively.


Further reading:


The UK government is set to encourage a million smokers to switch to e-cigarettes in a bid to reduce smoking rates to 5% or less.


The UK Vaping Industry Association: Banning flavored e-cigarettes could potentially lead to 1.5 million users returning to traditional cigarettes.


References:


Sales of traditional tobacco products have significantly decreased by 50% in a span of three years.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Executives of Flava, Flare, and Denkat Brands Sued by Philippines' BIR for Alleged Tax Evasion, Involving $160 Million
Executives of Flava, Flare, and Denkat Brands Sued by Philippines' BIR for Alleged Tax Evasion, Involving $160 Million
On April 29, the Philippines' BIR sued executives of Flava, Flare, and Denkat brands for failing to register and evading $160 million in taxes. The BIR accused them of violating the National Internal Revenue Code and pledged to pursue illegal e-cigarette operators and promoters.
Apr.29 by 2FIRSTS.ai
Brazilian Police Seize Nearly 20,000 Illegal E-cigarettes In Raid
Brazilian Police Seize Nearly 20,000 Illegal E-cigarettes In Raid
Brazilian federal highway police seized nearly 20,000 illegal e-cigarettes in a routine check, leading to the driver's detention.
Apr.28 by 2FIRSTS.ai
Utah E-Cigarette Ban Causes Consumers to Travel Across State Line to Wyoming for Purchases
Utah E-Cigarette Ban Causes Consumers to Travel Across State Line to Wyoming for Purchases
Utah e-cigarette ban leads consumers to cross state borders to Wyoming, impacting local retailers amid increasing sales.
Apr.17 by 2FIRSTS.ai
South Korea to Tighten Synthetic Nicotine Regulations: Reclassifies as Tobacco, Bans Online Sales and Flavor Additives
South Korea to Tighten Synthetic Nicotine Regulations: Reclassifies as Tobacco, Bans Online Sales and Flavor Additives
The South Korean National Assembly has proposed expanding the definition of tobacco, restricting online sales of e-cigarettes, and tightening regulations on synthetic nicotine in an effort to protect youth health.
Jun.13 by 2FIRSTS.ai
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
The U.S. Food and Drug Administration has officially launched Elsa, a generative AI tool designed to speed up clinical reviews, internal writing, and data processing tasks. After successful pilots across multiple departments, Elsa is now being rolled out agency-wide.
Jun.04 by 2FIRSTS.ai
JTI Plans to Produce Ploom X in the US
JTI Plans to Produce Ploom X in the US
JTI plans to produce Ploom X in the US due to Trump's tariff policies and supply chain trends, aiming for FDA approval.
May.28 by 2FIRSTS.ai